What is the share price of Manipal Health Enterprises Limited (MANIPALHOS) today?
The share price of MANIPALHOS as on 7th September 2026 is ₹727.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Manipal Health Enterprises Limited (MANIPALHOS) share?
The past returns of Manipal Health Enterprises Limited (MANIPALHOS) share are- Past 1 week: -6.39%
- Past 1 month: 11.48%
- Past 3 months: N/A%
- Past 6 months: 8.48%
- Past 1 year: 8.48%
- Past 3 years: N/A%
- Past 5 years: 8.48%
What are the peers or stocks similar to Manipal Health Enterprises Limited (MANIPALHOS)?
The peers or stocks similar to Manipal Health Enterprises Limited (MANIPALHOS) include:What is the market cap of Manipal Health Enterprises Limited (MANIPALHOS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Manipal Health Enterprises Limited (MANIPALHOS) is ₹94088.93 Cr as of 7th September 2026.What is the 52 week high and low of Manipal Health Enterprises Limited (MANIPALHOS) share?
The 52-week high of Manipal Health Enterprises Limited (MANIPALHOS) is ₹815 and the 52-week low is ₹625.45.What is the PE and PB ratio of Manipal Health Enterprises Limited (MANIPALHOS) stock?
The P/E (price-to-earnings) ratio of Manipal Health Enterprises Limited (MANIPALHOS) is 105.44. The P/B (price-to-book) ratio is 10.69.Which sector does Manipal Health Enterprises Limited (MANIPALHOS) belong to?
Manipal Health Enterprises Limited (MANIPALHOS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Manipal Health Enterprises Limited (MANIPALHOS) shares?
You can directly buy Manipal Health Enterprises Limited (MANIPALHOS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Manipal Health Enterprises Limited
MANIPALHOS Share Price
NSE₹727.250.53% (+3.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MANIPALHOS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgCurrent price is less than the intrinsic value
Red flags
LowNo red flag found
How to use scorecard? Learn more
MANIPALHOS Performance & Key Metrics
MANIPALHOS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 107.69 | 10.69 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 46.35 | 5.87 | 0.49% |
67%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
MANIPALHOS Company Profile
Manipal Health Enterprises Limited operates a pan-India network of 49 multispecialty hospitals and diagnostic centers under the Manipal Hospitals brand, providing comprehensive healthcare services including outpatient care, robotic spine surgery, bariatric surgery, oncology, cardiology, neurology, and emergency care across more than 24 cities such as Bengaluru, Delhi, Kolkata, and Pune.
APOLLOHOSP
PE Ratio
64.37
64.37
1Y Return
13.34%
13.34%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
67.48
67.48
1Y Return
13.84%
13.84%
Buy Reco %
84.00
84.00
FORTIS
PE Ratio
65.74
65.74
1Y Return
3.81%
3.81%
Buy Reco %
90.00
90.00
PE Ratio
171.03
171.03
1Y Return
24.12%
24.12%
Buy Reco %
90.91
90.91
MEDANTA
PE Ratio
68.05
68.05
1Y Return
2.26%
2.26%
Buy Reco %
88.89
88.89
MANIPALHOS Sentiment Analysis
MANIPALHOS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
MANIPALHOS Stock Summary · August 2026
Management said the quarter was robust, with strong volume-led growth across the network and a clear emphasis on scaling high-acuity care, digital channels and new capacity. Revenue rose more than 38% year on year to INR 3,091 crores, while network EBITDA increased more than 26% to INR 749 crores, supported by higher inpatient and outpatient volumes, better occupancy and improving monetization at the core network. High-acuity Centres of Excellence became a larger part of the mix, contributing about 65% of revenue, and oncology remained a fast-growing priority as its share rose to 12.2%. Digital and out-of-hospital offerings also gained importance, with digital revenue accounting for nearly a quarter of total revenue. Management acknowledged some tension between growth and margins, noting a slight year-on-year margin dip from ramp-up pressure at newer Bangalore greenfield hospitals, although ex-Sahyadri margins remained about 25%. Sahyadri itself improved, with revenue up over 13% and EBITDA up about 19% to 20%, but full convergence will take time. Near term, the company expects continued margin improvement as new hospitals mature, alongside a large expansion pipeline and debt reduction after IPO proceeds are used for repayment.
MANIPALHOS Stock Growth Drivers
MANIPALHOS Stock Growth Drivers
8Strong Volume-Led Revenue and EBITDA Growth
The company delivered a robust quarter with revenue rising more than 38% year on year
Scaling of Patient Volumes, Digital Channels, and Out-of-Hospital Care
The quarter showed broad-based operational momentum, with inpatient volumes up about 39%, outpatient volumes up
MANIPALHOS Stock Challenges
MANIPALHOS Stock Challenges
2Margin Pressure from Greenfield Ramp-Up and One-Off Comparisons
The company reported a clear year-over-year decline in ex-Sahyadri profitability, with Q1 margins falling from
Regional Payer-Mix Deterioration in the East
The East region is facing a less favorable payer mix as government business slows ahead
MANIPALHOS Forecast
MANIPALHOS Forecasts
Price
Revenue
Earnings
MANIPALHOS Share Price Forecast
MANIPALHOS Share Price Forecast
2026
Current
₹723.50
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹723.50
Baseline
Forecast for Sep 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MANIPALHOS Company Revenue Forecast
MANIPALHOS Company Revenue Forecast
2026
Current
₹10.52
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹10.52
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
MANIPALHOS Stock EPS (Earnings Per Share) Forecast
MANIPALHOS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹14.20
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹14.20
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
MANIPALHOS
MANIPALHOS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
MANIPALHOS Income Statement
MANIPALHOS Income Statement
Quarterly Normal View
| Quarter | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,285.98 | 2,523.37 | 2,793.32 | 2,917.85 | 3,165.19 | |||||
Operating & Other expenses | 1,669.55 | 1,798.65 | 2,130.34 | 2,200.04 | 2,369.49 | |||||
EBITDA | 616.43 | 724.72 | 662.98 | 717.81 | 795.70 | |||||
| Depreciation/Amortization | 140.63 | 150.85 | 203.38 | 184.69 | 187.25 | |||||
| PBIT | 475.80 | 573.87 | 459.60 | 533.12 | 608.45 | |||||
| Interest & Other Items | 131.61 | 156.07 | 287.39 | 289.22 | 293.27 | |||||
| PBT | 344.19 | 417.80 | 172.21 | 243.90 | 315.18 | |||||
| Taxes & Other Items | 93.82 | 106.69 | 18.95 | 66.25 | 83.53 | |||||
| Net Income | 250.37 | 311.11 | 153.26 | 177.65 | 231.65 | |||||
| EPS | 2.17 | 2.69 | 1.30 | 1.53 | 1.96 |
MANIPALHOS Company Updates
MANIPALHOS Stock Peers
MANIPALHOS Past Performance & Peer Comparison
MANIPALHOS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Manipal Health Enterprises Limited | 105.44 | 10.69 | — |
| Apollo Hospitals Enterprise Limited | 64.37 | 12.52 | 0.23% |
| Max Healthcare Institute Limited | 67.48 | 9.06 | 0.20% |
| Fortis Healthcare Ltd | 65.74 | 6.73 | 0.11% |
MANIPALHOS Stock Price Comparison
Compare MANIPALHOS with any stock or ETFCompare MANIPALHOS with any stock or ETF
MANIPALHOS
MANIPALHOS Holdings
MANIPALHOS Shareholdings
MANIPALHOS Promoter Holdings Trend
MANIPALHOS Promoter Holdings Trend
Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 9.34%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
MANIPALHOS Institutional Holdings Trend
MANIPALHOS Institutional Holdings Trend
No institutional holdings trend are available
MANIPALHOS Shareholding Pattern
MANIPALHOS Shareholding Pattern
MANIPALHOS Shareholding History
MANIPALHOS Shareholding History
Foreign Institutions
Mutual Funds Invested in MANIPALHOS
Mutual Funds Invested in MANIPALHOS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Manipal Health Enterprises Limited
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1168% | Percentage of the fund’s portfolio invested in the stock 0.16% | Change in the portfolio weight of the stock over the last 3 months 0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 73/74 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1168% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months 0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 60/65 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1166% | Percentage of the fund’s portfolio invested in the stock 3.01% | Change in the portfolio weight of the stock over the last 3 months 3.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 13/37 (+23) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MANIPALHOS stock
smallcases containing MANIPALHOS stock
Looks like this stock is not in any smallcase yet.
MANIPALHOS Events
MANIPALHOS Events
MANIPALHOS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MANIPALHOS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MANIPALHOS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MANIPALHOS has not given any dividends in last 5 years
MANIPALHOS Dividends
MANIPALHOS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeMANIPALHOS Stock News & Opinions
MANIPALHOS Stock News & Opinions
Articles & Videos
Earnings
Earnings
Manipal Health Enterprises Ltd consolidated sales up 7.23% on year in Q2FY2026, net profit saw a strong growth of 30.50%Manipal Health Enterprises Ltd share price declined by 2.73% to Rs 724.25. The Company's net profit surged by 30.50% to Rs 243.43 crore, while revenue from operations improved marginally 7.23% to Rs 3090.63 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.23 lakh crore, easing 7.46%. It has eased by 1.61% over last one week and spiked sharply by 25.80% in last one month while the market capitalization of Manipal Health Enterprises Ltd has remained flat Profit before tax (PBT) of Manipal Health Enterprises Ltd stood at Rs 315.18 crore in Q2 FY26, slipping 8.43% year-on-year, and surging by 29.23% quarter-on-quarter. EBITDA came in at Rs 662 crore, rallying 23.03% YoY and gaining 0.97% sequentially. Total expenses saw a slight increase of 6.96% to Rs 2541.27 crore in Q2FY26 over Q2FY25. During the quarter, employee benefits expense was at Rs 462.01 crore, jumping 18.03% YoY. For the TTM ended FY26, revenue from operations surged 25.40% to Rs 10335.75 crore, while net profit contracted by 15.26% to Rs 916.59 crore, compared to previous TTM. EBITDA soared by 217771% to Rs 2426.47 crore, and PBT slipped by 5.17% to Rs 1178.1 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 2078.4 crore in FY26, as against Rs 1569.83 crore in FY25.
2 weeks agoCapital Market - Live
Corporate
Corporate
Manipal Health Enterprises acquires Bengaluru’s Kinder Women’s Hospital for Rs 130 croreManipal Health Enterprises Limited has signed a Business Transfer Agreement with Kindorama Healthcare Private Limited to acquire the entire operations of the Kinder Women’s Hospital and Fertility Centre in Bengaluru, Karnataka, for a cash consideration of Rs 130 crore. The acquisition, which is allied to Manipal Hospitals' current business and expected to be completed within 90 days, will add a facility with 100 beds and revenue of Rs 20.75 crore for the fiscal year ended March 31, 2026.
3 weeks agoCapital Market - Live
Corporate
Corporate
Manipal Health Enterprises to review quarterly results at board meeting on August 20, 2026Manipal Health Enterprises Limited will hold a board meeting on Thursday, August 20, 2026, to consider and approve the unaudited financial results for both standalone and consolidated entities for the quarter ended June 30, 2026, along with a limited review report from statutory auditors; the company previously closed the trading window for its equity shares from August 5, 2026, until 48 hours after the financial results are made public.
3 weeks agoCapital Market - Live
Corporate
Corporate
Manipal Health Enterprises halts securities trading ahead of June 2026 financial resultsManipal Health Enterprises Limited will close its trading window for securities dealings from August 5, 2026, and reopen 48 hours after the announcement of its financial results for the quarter ended June 30, 2026, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
1 month agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 41.25%, vs industry avg of 17.92%
Over the last 5 years, market share increased from 4.25% to 10.24%